Status:
RECRUITING
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
Lead Sponsor:
Christopher Zachary
Conditions:
Basal Cell Carcinoma
Superficial Basal Cell Carcinoma
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Optical coherence tomography guided laser treatment of basal cell carcinoma
Detailed Description
The purpose of this pilot study is to examine the treatment basal cell carcinoma (BCC) with laser technology under the guidance of optical coherence tomography imaging (OCT). The laser modality that w...
Eligibility Criteria
Inclusion
- Ability to understand and carry out subject instructions or be represented by a legally authorized guardian or representative
- Ages 18 and older
- Seeks and is scheduled for treatment of a BCC previously confirmed with biopsy
Exclusion
- Any of the following will exclude participation in the study:
- Inability to understand and/or carry out instructions
- Patients with a BCC lesion that requires excision. This would include relatively large lesions (\>2.5 cm diameter), lesions that penetrate deep into the skin beyond the depth of the OCT image capture, high risk lesions as defined by the American Academy of Dermatology as recurrent and sclerosing subtype BCC, or metastases.
- Patients with periocular BCCs which might expose the patient to risk of damage to eyes from the laser.
- BCCs on legs due to their tendency towards poor wound healing.
- Pregnancy
- Patients unable to follow-up for the full 12 months.
Key Trial Info
Start Date :
January 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04744935
Start Date
January 13 2021
End Date
December 31 2025
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCI Health Gottschalk Medical Plaza
Irvine, California, United States, 92617